ClinicalTrials.gov
public full text
Public Domain
Effects of BFRT on Glycemic Control, Nerve Conduction, Functional Outcomes and QOL in Individuals With Type 2 Diabetes
Diabetic peripheral neuropathy is one of the most prevalent complications of Type 2 Diabetes Mellitus. Peripheral neuropathy is caused by unavailability of glucose in cells and low metabolism. The Blood flow restriction training cause glucose diffusion into cell and Angiogenesis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain#1114349
- Pharmacological treatment for painful and symptomatic diabetic neuropathy - a systematic review and network meta-analysis / Velina Vasileva Shishkova-Stoev ; Gutachter: Sabrina Schlesinger, Brenda Wilhelma Corinna Bongaerts#983186
- Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy#398250
- Clinical Trial for the Investigational Drug (PB-201) in Subjects With Type 2 Diabetes Mellitus#314268
- Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes#668943
Record · ID 1059533
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive